South African Vaccination and Immunisation Centre
South African Vaccination and Immunisation Centre South African Vaccination and Immunisation Centre
HomeAbout UsDiseases and VaccinesImmunisation ResourcesReports and PublicationsContact Us
 
PDF Printable Version

Diseases & Vaccines / More Vaccine Preventable Diseases / Rabies / Vaccine

VACCINE: RABIES

vaccine indicationrationale for vaccinationtype of vaccinecomposition of the vaccineimmunogenity of vaccinesefficacy and long-term protectioncandidates for vaccinationvaccination regimen and route of administrationinterchangeability of vaccinessafety and special precautions

1.     Vaccine indication

Rabies vaccination is indicated for the primary active prevention of rabies in persons at increased risk of infection with the rabies virus, and also as a post-exposure prophylactic in persons infected with the rabies virus, to prevent the development of rabies clinical disease.

2.     Rationale for vaccination

Rabies is currently an incurable disease, with antiviral drugs, interferon, and rabies immunoglobulin been used to treat human disease only prolonging the disease and having no impact on the fatalities. However, rabies vaccine used as pre-exposure prophylaxis is 100% effective in preventing death due to rabies.

3.     Type of vaccine

Inactivated rabies vaccine.

4.     Composition of the vaccine

Rabies vaccines are prepared from inactivated rabies virus strains cultured in the following cell lines (i) human diploid cell culture; (ii) vero cell culture; (iii) chick embryo cell culture; and (iv) duck embryo cell culture. The virus strains are inactivated by ß-propiolactone and purified by zonal centrifugation and ultrafiltration. The vaccine is stored at 20C to 80C, is never frozen and must be protected from light.

5.     Immunogenicity of vaccines

An immune response to the rabies vaccine can be detected 7 days after vaccination. Three doses of the rabies vaccine induce antibody production in 100% of the vaccinees. Persons above 50 years of age respond less well than younger persons but all seroconvert after 5 doses.

6.     Efficacy and long-term protection

Rabies vaccine is highly effective in preventing disease although booster doses are recommended every 2 to 3 years for individuals frequently at risk of exposure. 
 
7.     Candidates for vaccination

Rabies vaccine is not available as part of the EPI (SA) schedule, however there are persons who are at an increased risk of rabies virus infection and should be vaccinated. They include the following:

  • Children under 15 years of age
  • Laboratory staff
  • Veterinarians
  • Animal handlers
  • Game rangers with frequent exposure to potentially infected animals
  • Travellers to rabies endemic regions

8.     Vaccination regimen and route of administration

The vaccine is given by intramuscular injection to the deltoid muscle.

  • Pre-exposure prophylaxis

    Three doses of the vaccine are given on days 0, 7, and 28, with a booster   dose after 1 year.
  • Post-exposure prophylaxis

    As post-exposure prophylaxis (PEP), rabies vaccine should be given according to WHO guidelines. Exposure to rabies-infected material is classified into 3 categories, and PEP is administered based on these categories

Category Type of contact Recommended treatment
   I Touching or feeding of animals
Licks of intact skin
None, if reliable case history is available
  II Nibbling on unbroken skin
Minor scratches without bleeding
Licks on broken skin
Administer rabies immunoglobulin and vaccine immediately. Further doses of the vaccine are given on days 3, 7, 14 and 28. Stop treatment if animal remains healthy after 10 days of observation or laboratory tests are negative for rabies
 III Single or multiple transdermal bites or scratches
Contamination of mucous membrane with saliva
Administer rabies immunoglobulin and vaccine immediately. Further doses of the vaccine are given on days 3, 7, 14 and 28. Stop treatment if animal remains healthy after 10 days of observation or laboratory tests are negative for rabies

9.     Interchangeability of vaccines

It is recommended that one type of vaccine be used to complete a vaccination schedule. However, when completion of a vaccination schedule with the same vaccine is not possible, the switch can be done provided it is one of the WHO recommended cell culture vaccines.

10.   Side effects and special precautions

The current rabies vaccines are safe. The common side effects are pain, swelling and itching at the site of injection accompanied by mild fever.

REFERENCES

 



Last Updated: 12-07-2010

Search
Online Subscription
Online Quiz
Meetings and Events
Savic Projects
News Archive
Site Feedback
Site Map / Legal Disclaimer / Privacy Policy / © Copyright University of Limpopo 2005 - 2010